Showing results (381-390 of 1,873) with videos related to

Sort By:
Pageof 188
Pulmonary Pharmacology & Therapeutics|March 14, 2022
Mechanistic insights into the amelioration effects of lipopolysaccharide-induced acute lung injury by baicalein: An integrated systems pharmacology study and experimental validationZhi-Dan Gao, Hai-Dong Yan, Ning-Hua Wu, et al.
Pulmonary Pharmacology & Therapeutics|September 16, 2018
Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: Results of a single-centre observational studyCorrado Pelaia, Maria Teresa Busceti, Sabina Solinas, et al.
Pulmonary Pharmacology & Therapeutics|October 10, 2019
Safety, pharmacokinetics and pharmacodynamics of a novel anti-asthmatic drug, XC8, in healthy probandsAndreas Renner, Julia Romanova, Boris Ferko, et al.
Pulmonary Pharmacology & Therapeutics|September 24, 2018
Andrographolide prevented toluene diisocyanate-induced occupational asthma and aberrant airway E-cadherin distribution via p38 MAPK-dependent Nrf2 inductionIbrahim Sulaiman, Khaishin Tan, Norhafizah Mohtarrudin, et al.
Pulmonary Pharmacology & Therapeutics|April 3, 2018
Emerging biological therapies for treating chronic obstructive pulmonary disease: A pairwise and network meta-analysisPaola Rogliani, Maria Gabriella Matera, Ermanno Puxeddu, et al.
Pulmonary Pharmacology & Therapeutics|March 31, 2023
Weight loss in nintedanib-treated patients with idiopathic pulmonary fibrosisHiromi Tomioka, Masaaki Iwabayashi, Makoto Yokota, et al.
Pulmonary Pharmacology & Therapeutics|April 7, 2021
The pharmacology of the prostaglandin D2 receptor 2 (DP2) receptor antagonist, fevipiprantChris Brightling, Swarupa Kulkarni, Bart N Lambrecht, et al.
Pulmonary Pharmacology & Therapeutics|July 10, 2012
Doxycycline exhibits anti-inflammatory activity in CF bronchial epithelial cellsTimothy J Bensman, Albert N Nguyen, Adupa P Rao, et al.
Pulmonary Pharmacology & Therapeutics|September 13, 2012
Models to study airway smooth muscle contraction in vivo, ex vivo and in vitro: implications in understanding asthmaDavid Wright, Pawan Sharma, Min-Hyung Ryu, et al.
Pulmonary Pharmacology & Therapeutics|August 18, 2020
Dihydroquercetin attenuates lipopolysaccharide-induced acute lung injury through modulating FOXO3-mediated NF-κB signaling via miR-132-3pJian-Hua Liu, Liang Cao, Chang-Hong Zhang, et al.
Pageof 188